ArticleNeurosurgical review2025
Volumetric assessment in chronic subdural hematoma: a predictor of recurrence and guide for adjunctive therapy.
Article in Neurosurgical review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic subdural hematoma (cSDH) is the most common form of intracranial hemorrhage, with increasing incidence in older population. Despite surgical interventions, recurrence rates remain high, varying between 5 and 37%. Identifying predictors of recurrence, particularly preoperative volumetric thresholds, could change treatment strategies such as middle meningeal artery (MMA) embolization. In this study, 104 patients undergoing burr-hole craniotomy were analyzed. Patients with bilateral hematomas or insufficient radiological data were excluded. Hematoma volume was assessed preoperatively and during follow-up, with recurrence defined as requiring reoperation. While no significant gender differences were found in recurrence rates or hematoma characteristics, preoperative hematoma volume (p = 0.024) and follow-up volume (p < 0.001) were significantly associated with recurrence. Using ROC analysis, a cutoff preoperative volume of 112 mL for females and 130 mL for males was identified, predicting recurrence with high specificity (88.9% in females, 87.5% in males). These findings highlight the importance of volumetric assessment in predicting cSDH recurrence. Integrating these thresholds into clinical decision-making may guide the use of adjunctive therapies, such as MMA embolization, in high-risk patients.
Indexed as
Identifiers
41273431What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.